Advertisement
Screener

Tilray Brands, Inc. (TLRY) Payments to Acquire Productive Assets

2.3 / 5 stars · 30/64 Roast Me

Tilray Brands, Inc. Payments to Acquire Productive Assets

Tilray Brands, Inc. (TLRY) reported Payments to Acquire Productive Assets of $32.92 million for the 12-month period ending 2025-05-31, per its 10-K filed 2025-07-29.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireProductiveAssets · last filed 2025-07-29

  • Tilray Brands, Inc. payments to acquire productive assets for the quarter ending 2025-05-31 was $6.33M, a 34.80% decline year-over-year.
  • Tilray Brands, Inc. payments to acquire productive assets for the quarter ending 2025-02-28 was $14.41M, a 51.28% increase year-over-year.
  • Tilray Brands, Inc. payments to acquire productive assets for the quarter ending 2024-11-30 was $5.44M, a 7.22% decline year-over-year.
  • Tilray Brands, Inc. payments to acquire productive assets for the quarter ending 2024-08-31 was $6.74M, a 62.24% increase year-over-year.
  • Tilray Brands, Inc. payments to acquire productive assets for fiscal 2025 was $32.92M, a 12.54% increase from fiscal 2024.
  • Tilray Brands, Inc. payments to acquire productive assets for fiscal 2024 was $29.25M, a 40.62% increase from fiscal 2023.
  • Tilray Brands, Inc. payments to acquire productive assets for fiscal 2023 was $20.80M, a 38.94% decline from fiscal 2022.
  • Tilray Brands, Inc. payments to acquire productive assets for fiscal 2022 was $34.06M, a 12.37% decline from fiscal 2021.
Period endPayments to Acquire Productive Assets 3 monthPayments to Acquire Productive Assets 6 monthPayments to Acquire Productive Assets 9 monthPayments to Acquire Productive Assets 12 month
2025-05-31$6.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29
$20.75M
derived: sum of 2 quarters · filed 2025-07-29
$26.18M
derived: sum of 3 quarters · filed 2025-07-29
$32.92M
10-K · filed 2025-07-29
2025-02-28$14.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08
$19.85M
derived: sum of 2 quarters · filed 2025-04-08
$26.59M
10-Q · filed 2025-04-08
$36.30M
derived: sum of 4 quarters · filed 2025-07-29
2024-11-30$5.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10
$12.17M
10-Q · filed 2025-01-10
$21.88M
derived: sum of 3 quarters · filed 2025-07-29
$31.41M
derived: sum of 4 quarters · filed 2025-07-29
2024-08-31$6.74M
10-Q · filed 2024-10-10
$16.45M
derived: sum of 2 quarters · filed 2025-07-29
$25.97M
derived: sum of 3 quarters · filed 2025-07-29
$31.83M
derived: sum of 4 quarters · filed 2025-07-29
2024-05-31$9.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29
$19.24M
derived: sum of 2 quarters · filed 2025-07-29
$25.10M
derived: sum of 3 quarters · filed 2025-07-29
$29.25M
10-K · filed 2025-07-29
2024-02-29$9.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08
$15.39M
derived: sum of 2 quarters · filed 2025-04-08
$19.54M
10-Q · filed 2025-04-08
$31.95M
derived: sum of 4 quarters · filed 2025-07-29
2023-11-30$5.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10
$10.01M
10-Q · filed 2025-01-10
$22.42M
derived: sum of 3 quarters · filed 2025-07-29
$23.27M
derived: sum of 4 quarters · filed 2025-07-29
2023-08-31$4.15M
10-Q · filed 2024-10-10
$16.56M
derived: sum of 2 quarters · filed 2025-07-29
$17.41M
derived: sum of 3 quarters · filed 2025-07-29
$21.95M
derived: sum of 4 quarters · filed 2025-07-29
2023-05-31$12.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29
$13.26M
derived: sum of 2 quarters · filed 2025-07-29
$17.80M
derived: sum of 3 quarters · filed 2025-07-29
$20.80M
10-K · filed 2025-07-29
2023-02-28$857.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09
$5.39M
derived: sum of 2 quarters · filed 2024-04-09
$8.39M
10-Q · filed 2024-04-09
$13.99M
derived: sum of 4 quarters · filed 2024-10-10
2022-11-30$4.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09
$7.54M
10-Q · filed 2024-01-09
$13.13M
derived: sum of 3 quarters · filed 2024-10-10
$17.75M
derived: sum of 4 quarters · filed 2024-10-10
2022-08-31$3.00M
10-Q · filed 2024-10-10
$8.59M
derived: sum of 2 quarters · filed 2024-10-10
$13.21M
derived: sum of 3 quarters · filed 2024-10-10
$20.75M
derived: sum of 4 quarters · filed 2024-10-10
2022-05-31$5.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30
$10.21M
derived: sum of 2 quarters · filed 2024-07-30
$17.75M
derived: sum of 3 quarters · filed 2024-07-30
$34.06M
10-K · filed 2024-07-30
2022-02-28$4.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10
$12.15M
derived: sum of 2 quarters · filed 2023-04-10
$28.47M
10-Q · filed 2023-04-10
$33.41M
derived: sum of 4 quarters · filed 2023-07-26
2021-11-30$7.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09
$23.86M
10-Q · filed 2023-01-09
$28.80M
derived: sum of 3 quarters · filed 2023-07-26
$32.87M
derived: sum of 4 quarters · filed 2023-07-26
2021-08-31$16.32M
10-Q · filed 2022-10-07
$21.26M
derived: sum of 2 quarters · filed 2023-07-26
$25.33M
derived: sum of 3 quarters · filed 2023-07-26
$41.23M
derived: sum of 4 quarters · filed 2023-07-26
2021-05-31$4.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26
$9.01M
derived: sum of 2 quarters · filed 2023-07-26
$24.92M
derived: sum of 3 quarters · filed 2023-07-26
$38.87M
10-K · filed 2023-07-26
2021-02-28$4.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06
$19.98M
derived: sum of 2 quarters · filed 2022-04-06
$33.93M
10-Q · filed 2022-04-06
2020-11-30$15.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10
$29.86M
10-Q · filed 2022-01-10
2020-08-31$13.96M
10-Q · filed 2021-10-07
2020-05-31$98.79M
10-K · filed 2022-07-28
2019-05-31$155.75M
10-K · filed 2021-07-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87